the relationship of high serum il2r levels to an adverse clinical outcome in hodgkin 's disease may be explained by a model in which the soluble receptor competes for the ligand with the cellular receptor on normal lymphocytes , thus blocking antitumor immunity dependent on interleukin-2 .
C0019829
hodgkin 's disease
C0024264
lymphocytes